These can be used to inform studies in neurologic and psychiatric illnesses, cancer, diabetes and other illnesses, but also, through NIH-funded data sharing agreements, can be used to increase the statistical power for minority populations in genome-wide association studies, which are currently unable to address many questions in medically underserved Hispanic minority patients.